TARS 8-K/A 2026-10-13

Tarsus Pharmaceuticals, Inc. (TARS) 8-K/A dated 2026-10-13 — accession 0001819790-26-000069. This URL is the filing, not the TARS hub.

Tarsus Pharmaceuticals, Inc. (TARS) is a biotechnology company listed on NASDAQ.

Tarsus Pharmaceuticals, Inc. filed a 8-K/A on 2026-10-13. Accession 0001819790-26-000069.

Cached items: 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported TARS revenue for 2025-12-31 was $451.4M. Net income was -$66.4M. Revenue was up 146.7% from 2024-12-31 to 2025-12-31. TARS currently screens at market cap $2.66B.

Not investment advice. The TARS SEC hub lists recent forms. The stock page is the research view.